SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Jun 2022
Historique:
received: 29 04 2022
revised: 29 05 2022
accepted: 30 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Being in the epicenter of the COVID-19 pandemic, our lab tested 193,054 specimens for SARS-CoV-2 RNA by diagnostic multiplex reverse transcription polymerase chain reaction (mRT-PCR) starting in March 2020, of which 17,196 specimens resulted positive. To investigate the dynamics of virus molecular evolution and epidemiology, whole genome amplification (WGA) and Next Generation Sequencing (NGS) were performed on 9516 isolates. 7586 isolates with a high quality were further analyzed for the mutation frequency and spectrum. Lastly, we evaluated the utility of the mRT-PCR detection pattern among 26 reinfected patients with repeat positive testing three months after testing negative from the initial infection. Our results show a continuation of the genetic divergence in viral genomes. Furthermore, our results indicate that independent mutations in the primer and probe regions of the nucleocapsid gene amplicon and envelope gene amplicon accumulate over time. Some of these mutations correlate with the changes of detection pattern of viral targets of mRT-PCR. Our data highlight the significance of a continuous genetic divergence on a gene amplification-based assay, the value of the mRT-PCR detection pattern for complementing the clinical diagnosis of reinfection, and the potential for WGA and NGS to identify mutation hotspots throughout the entire viral genome to optimize the design of the PCR-based gene amplification assay.

Identifiants

pubmed: 35682933
pii: ijms23116254
doi: 10.3390/ijms23116254
pmc: PMC9181733
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : the National key research and development program
ID : 2021YFC2301300
Organisme : the CAMS Innovation Fund for Medical Sciences
ID : 2021-I2M-1-061
Organisme : the National Natural Science Foundation of China
ID : 92169106

Références

Science. 2020 Aug 14;369(6505):818-823
pubmed: 32616673
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32513858
Nat Med. 2021 Jul;27(7):1131-1133
pubmed: 34045737
J Mol Diagn. 2011 Nov;13(6):583-604
pubmed: 21871973
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
R Soc Open Sci. 2020 Jun 10;7(6):200636
pubmed: 32742701
Clin Chem. 2013 Oct;59(10):1470-80
pubmed: 24014836
J Mol Diagn. 2010 Jan;12(1):109-17
pubmed: 19948821
World J Gastroenterol. 2016 Nov 21;22(43):9604-9612
pubmed: 27920481
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Clin Virol. 2005 Oct;34(2):104-7
pubmed: 16157260
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
J Infect. 2021 Feb;82(2):282-327
pubmed: 32800801
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Dakai Liu (D)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

George D Rodriguez (GD)

Division of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Hang-Yu Zhou (HY)

Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Suzhou Institute of Systems Medicine, Suzhou 215123, China.

Ye-Xiao Cheng (YX)

Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Suzhou Institute of Systems Medicine, Suzhou 215123, China.

Xiaofeng Li (X)

National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou 510182, China.

Wenwen Tang (W)

Vascular Biology and Therapeutics Program, Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.

Nishant Prasad (N)

Division of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Chun-Cheng Chen (CC)

Department of Surgery, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Vishnu Singh (V)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Eric Konadu (E)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Keither K James (KK)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Maria F Bahamon (MF)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Yvonne Chen (Y)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Sorana Segal-Maurer (S)

Division of Infectious Disease, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.

Aiping Wu (A)

Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Suzhou Institute of Systems Medicine, Suzhou 215123, China.

William Harry Rodgers (WH)

Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens, 56-45 Main Street Flushing, New York, NY 11355, USA.
Department of Pathology and Laboratory Medicine, Weil Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH